143 related articles for article (PubMed ID: 35842583)
1. Excimer laser ablation combined with drug-coated balloon versus drug-coated balloon in the treatment of de novo atherosclerotic lesions in lower extremities (ELABORATE): study protocol for a real-world clinical trial.
Jiang X; Fan L; Chen B; Jiang J; Liu J; Qiao G; Ju S; Shi Y; Ma T; Lin C; Fang G; Guo D; Xu X; Dong Z; Fu W
BMC Cardiovasc Disord; 2022 Jul; 22(1):317. PubMed ID: 35842583
[TBL] [Abstract][Full Text] [Related]
2. Safety and Effectiveness of Excimer Laser Ablation Combined With Drug-Coated Balloon for Atherosclerotic Obliterans in the Lower Extremity.
Jiang X; Ju S; Chen B; Jiang J; Shi Y; Ma T; Lin C; Xu X; Fu W; Dong Z
J Endovasc Ther; 2023 Oct; 30(5):721-729. PubMed ID: 35514287
[TBL] [Abstract][Full Text] [Related]
3. Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of femoropopliteal arteriosclerosis obliterans.
Su Z; Li Y; Yang S; Guo J; Guo L; Gu Y
Ann R Coll Surg Engl; 2022 Nov; 104(9):667-672. PubMed ID: 35446161
[TBL] [Abstract][Full Text] [Related]
4. The safety and efficacy of different endovascular treatments for in-stent restenosis of the femoropopliteal artery: A network meta-analysis.
He Z; Wang H; Lin F; Ding W; Chen K; Zhang Z
Vasc Med; 2022 Jun; 27(3):239-250. PubMed ID: 35164613
[No Abstract] [Full Text] [Related]
5. Results of Excimer Laser Ablation Combined with Drug-Coated Balloon for Atherosclerotic Obliterans of Lower Extremity and Risk Factors for Loss of Primary Patency.
Jiang X; Li X; Chen B; Jiang J; Shi Y; Ma T; Lin C; Guo D; Xu X; Ju S; Fu W; Dong Z
Ann Vasc Surg; 2023 Apr; 91():223-232. PubMed ID: 36584966
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Excimer Laser Ablation Combined with Drug-coated Balloon in Atherosclerotic Lesions of the Popliteal Artery.
Jiang X; Ju S; Liu H; Chen B; Jiang J; Shi Y; Ma T; Lin C; Fang G; Guo D; Xu X; Fu W; Dong Z
Ann Vasc Surg; 2024 Jul; 104():196-204. PubMed ID: 38492729
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Excimer Laser Atherectomy Combined with a Drug-Coated Balloon in De Novo Femoral Popliteal Artery Disease: A Retrospective Study.
Pan D; Guo J; Su Z; Meng W; Wang C; Guo J; Gu Y
Ann Vasc Surg; 2024 Feb; 99():26-32. PubMed ID: 37914073
[TBL] [Abstract][Full Text] [Related]
8. Excimer laser atherectomy combined with drug-coated balloon versus drug-eluting balloon angioplasty for the treatment of infrapopliteal arterial revascularization in ischemic diabetic foot: 24-month outcomes.
Yang S; Li S; Hou L; He J
Lasers Med Sci; 2022 Apr; 37(3):1531-1537. PubMed ID: 34647190
[TBL] [Abstract][Full Text] [Related]
9. Randomized Trial of Chocolate Touch Compared With Lutonix Drug-Coated Balloon in Femoropopliteal Lesions (Chocolate Touch Study).
Shishehbor MH; Zeller T; Werner M; Brodmann M; Parise H; Holden A; Lichtenberg M; Parikh SA; Kashyap VS; Pietras C; Tirziu D; Ardakani S; Beschorner U; Krishnan P; Niazi KA; Wali AU; Lansky AJ
Circulation; 2022 May; 145(22):1645-1654. PubMed ID: 35377157
[TBL] [Abstract][Full Text] [Related]
10. [Application and value of excimer laser ablation in the treatment of lower limb atherosclerotic obliterans].
Jiang XL; Ju S; Chen B; Jiang JH; Shi Y; Ma T; Lin CP; Guo DQ; Xu X; Dong ZH; Fu WG
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(14):1026-1030. PubMed ID: 33845542
[No Abstract] [Full Text] [Related]
11. Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort.
Torsello G; Stavroulakis K; Brodmann M; Micari A; Tepe G; Veroux P; Benko A; Choi D; Vermassen FEG; Jaff MR; Guo J; Dobranszki R; Zeller T;
J Endovasc Ther; 2020 Oct; 27(5):693-705. PubMed ID: 32583749
[No Abstract] [Full Text] [Related]
12. Drug-Coated Balloon Angioplasty Versus Standard Uncoated Balloon Angioplasty for Long Femoropopliteal Lesions: Post Hoc Analysis of the 24-Month Results of the AcoArt I Study.
Jia S; Liu J; Sun G; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
Ann Vasc Surg; 2022 May; 82():70-80. PubMed ID: 34902474
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
Imran HM; Hyder ON; Soukas PA
Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
[TBL] [Abstract][Full Text] [Related]
14. Atherectomy and Drug-Coated Balloon Angioplasty for the Treatment of Long Infrapopliteal Lesions: A Randomized Controlled Trial.
Rastan A; Brodmann M; Böhme T; Macharzina R; Noory E; Beschorner U; Flügel PC; Bürgelin K; Neumann FJ; Zeller T
Circ Cardiovasc Interv; 2021 Jun; 14(6):e010280. PubMed ID: 34092093
[TBL] [Abstract][Full Text] [Related]
15. Drug-coated Balloon Angioplasty of Femoropopliteal Lesions Maintained Superior Efficacy over Conventional Balloon: 2-year Results of the Randomized EffPac Trial.
Teichgräber U; Lehmann T; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Blessing E; Lichtenberg M; von Flotow P; Heilmeier B; Sixt S; Brucks S; Erbel C; Beschorner U; Werk M; Riambau V; Wienke A; Klumb CT; Thieme M
Radiology; 2020 May; 295(2):478-487. PubMed ID: 32125256
[TBL] [Abstract][Full Text] [Related]
16. Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Proximal Popliteal Arteries: One-Year Results of the MDT-2113 SFA Japan Randomized Trial.
Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H;
J Endovasc Ther; 2018 Feb; 25(1):109-117. PubMed ID: 29264999
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-Coated Balloon vs Uncoated Balloon Angioplasty for Treatment of In-Stent Restenosis in the Superficial Femoral and Popliteal Arteries: The COPA CABANA Trial.
Tepe G; Schroeder H; Albrecht T; Reimer P; Diehm N; Baeriswyl JL; Brechtel K; Speck U; Zeller T
J Endovasc Ther; 2020 Apr; 27(2):276-286. PubMed ID: 32096451
[No Abstract] [Full Text] [Related]
18. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
[TBL] [Abstract][Full Text] [Related]
19. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
Stavroulakis K; Schwindt A; Torsello G; Stachmann A; Hericks C; Bosiers MJ; Beropoulis E; Stahlhoff S; Bisdas T
J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
Shammas NW; Shammas GA; Jones-Miller S; Shammas WJ; Bou-Dargham B; Shammas AN; Banerjee S; Rachwan RJ; Daher GE
Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
